Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158195 (US9029364, 1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | US Patent | 0.380 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158195 (US9029364, 1) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 0.840 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158205 (US9029364, 3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 0.900 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158197 (US9029364, 5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158199 (US9029364, 8) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158197 (US9029364, 5) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 5.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158202 (US9029364, 13) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 7.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158205 (US9029364, 3) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158196 (US9029364, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 9.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158204 (US9029364, 2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 15.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158196 (US9029364, 4) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158201 (US9029364, 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158206 (US9029364, 6) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158204 (US9029364, 2) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158198 (US9029364, 7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158199 (US9029364, 8) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 75.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158194 (US9029364, 17) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158201 (US9029364, 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 101 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158200 (US9029364, 10) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158198 (US9029364, 7) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 121 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158207 (US9029364, 9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 150 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158203 (US9029364, 14) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 155 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158192 (US9029364, 15) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 170 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158200 (US9029364, 10) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 192 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158193 (US9029364, 16) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 260 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158206 (US9029364, 6) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 346 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158193 (US9029364, 16) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158202 (US9029364, 13) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.12E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158208 (US9029364, 11) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | >1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158207 (US9029364, 9) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | >1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158203 (US9029364, 14) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | >1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158192 (US9029364, 15) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin/Hypocretin receptor type 1 (Homo sapiens (Human)) | BDBM158194 (US9029364, 17) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Orexin receptor type 2 (Homo sapiens (Human)) | BDBM158208 (US9029364, 11) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | >4.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho... | US Patent US9029364 (2015) BindingDB Entry DOI: 10.7270/Q2SF2TX1 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
